Wegovy Cost Per Month: Turning the Sticker Into a Number

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Turning "per month" into a real number

When people ask what Wegovy costs per month, they are usually trying to build a budget line, not memorize a list price. The honest answer is that the monthly figure is personal: it is assembled from your coverage, the indication on your prescription, savings-card eligibility, pharmacy pricing, and whether a compounded alternative is in play. This guide reframes the sticker into something you can actually plan around.

Browse the full PlexusDx Education Hub library on GLP-1 therapies, weight protocols, and metabolic genetics.

The sticker price versus your price

Wegovy list price is approximately $1,349 per month at U.S. list as of April 2026, per Novo Nordisk's published pricing. That is the number before your plan touches it. Rebates, formulary placement, prior authorization, and the indication written on your script all move the final amount, and most insured patients never pay the full sticker. So the useful question is not "what is list" but "what is mine."

How your plan decides

A commercial plan's answer depends on the indication and its own formulary rules. GLP-1 coverage for type 2 diabetes is widespread; chronic weight management coverage varies far more, often behind BMI-based prior authorization, and some plans exclude weight indications entirely. Medicare does not cover FDA-approved weight-management drugs for weight alone as of April 2026, though some products carry cardiovascular-indication coverage. Confirm the details with your plan.

Trimming the monthly bill

Manufacturer savings card

Novo Nordisk's savings card can lower monthly cost substantially for eligible commercially-insured patients, but it typically excludes Medicare, Medicaid, and TRICARE and carries monthly and annual caps. Terms change, so verify at fill time.

Pharmacy discount cards

GoodRx and SingleCare publish coupon prices that vary by pharmacy. Comparing the card against your insurance price often reveals which route is cheaper that month.

Where compounded protocols sit

During the FDA-declared shortages, 503A pharmacies legally compounded semaglutide and tirzepatide. The semaglutide shortage was resolved in late 2024 and the tirzepatide shortage in early 2025, narrowing the compounding window but not ending all legitimate activity. Compounded versions remain available through licensed pathways where justified, are priced separately from the brand, and are not identical products. Realistically, monthly cost ranges from as little as $25 with covered insurance and a savings card, to near-list when the indication is not covered, to near-list cash without insurance, where compounded protocols offer a separate structure.

Budgeting with your biology in view

A monthly budget is easier to justify when you understand what the money is buying at the biological level. That understanding starts before the first refill.

Upstream of any GLP-1 decision, the PlexusDx Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights, mapping variants such as FTO, and MC4R that shape your baseline appetite, satiety, and energy-balance biology. It never predicts how you will respond to a specific drug, and it is not a drug-response predictor; it simply gives you the metabolic backdrop to bring into a provider conversation. That is the test-before-you-invest sequence PlexusDx applies to every protocol: understand the biology first, then weigh the options with a clinician rather than guessing. To see the compounded protocols that pair with that context, explore the Weight Management Protocols collection, all delivered through licensed 503A compounding.

Building a realistic monthly plan

Turning cost into a plan means budgeting for the range rather than a single figure. A sensible approach is to confirm your coverage and indication first, then check both your insurance price and a pharmacy discount card, and finally compare a compounded protocol if self-paying makes sense. Because savings-card terms and coupon prices change, revisiting the number every few fills keeps the budget accurate. It also helps to separate the recurring drug cost from one-time or periodic costs like an evaluation, so the monthly line item reflects what actually repeats. A plan built on your real coverage beats one built on a headline you saw online.

Frequently Asked Questions

How much does Wegovy cost per month?

List price is about $1,349 per month at U.S. list as of April 2026, per Novo Nordisk's published pricing. Your actual monthly number depends on insurance, savings cards, and pharmacy pricing, which can shift it well below or near list. Confirm with the pharmacy before you fill.

Can my monthly cost really drop to $25?

For some patients, yes. With commercial insurance that covers the indication and the manufacturer savings card applied, eligible patients may pay as little as $25 per month, depending on plan terms and caps. Government-insurance patients are generally excluded from the card, so results vary.

Does insurance cover Wegovy?

Coverage depends on the plan, formulary, the FDA indication on the prescription, and prior authorization. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes; chronic weight management coverage is more variable. Medicare does not cover weight-management indications for weight alone as of April 2026.

Are lower-cost monthly alternatives available?

Licensed compounding pharmacies prepare compounded semaglutide and tirzepatide at separate price points from the brand. They are legally and factually different, not generics. PlexusDx offers both through its Weight Management Protocols, with per-protocol pricing published on each product page for a like-for-like comparison.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.